首页 › 基金 › Decheng Capital LLC › PYXS
Decheng Capital LLC 对 PYXS 的持仓历史
PYXIS ONCOLOGY INC · 医疗保健
Decheng Capital LLC 在 Q3 2026 的 13F 申报中披露持有 PYXS(PYXIS ONCOLOGY INC)326,810 股,市值约 US$761K,约占其申报组合的 0.11%,在其申报持仓中市值排名第 11 位。 Decheng Capital LLC 最近 12 个申报季度中有 12 个季度披露了 PYXS 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Decheng Capital LLC 对 PYXS 的持仓演变
Decheng Capital LLC 于 Q4 2023 首次披露 PYXS 持仓:326,810 股(约 US$588K)。 该持仓在 Q1 2024 达到峰值 326,810 股,市值约 US$1.4M。 在 12 次申报中,Decheng Capital LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 326,810 股、市值约 US$761K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 326.81K | $588.26K | 新进 |
| Q1 2024 | 326.81K | $1.39M | 持有 |
| Q2 2024 | 326.81K | $1.08M | 持有 |
| Q3 2024 | 326.81K | $1.20M | 持有 |
| Q4 2024 | 326.81K | $509.82K | 持有 |
| Q1 2025 | 326.81K | $320.24K | 持有 |
| Q2 2025 | 326.81K | $359.49K | 持有 |
| Q3 2025 | 326.81K | $725.52K | 持有 |
| Q4 2025 | 326.81K | $375.83K | 持有 |
| Q1 2026 | 326.81K | $477.14K | 持有 |
| Q2 2026 | 326.81K | $983.70K | 持有 |
| Q3 2026 | 326.81K | $761.47K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 PYXS 与 13F 数据
PYXS(PYXIS ONCOLOGY INC)属于医疗保健行业。我们追踪的基金中还有 32 只申报持有 PYXS,申报仓位最大的包括:GordonMD Global Investments LP (US$30.2M), PFIZER INC (US$20.1M), Laurion Capital Management LP (US$11.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 PYXS 的基金
- GordonMD Global Investments LP 10.02M 股 · $30.17M · Q2 2026
- PFIZER INC 7.03M 股 · $20.11M · Q3 2026
- Laurion Capital Management LP 4.99M 股 · $11.63M · Q3 2026
- Palo Alto Investors LP 864.28K 股 · $2.60M · Q2 2026
- Blue Owl Capital Holdings LP 1.00M 股 · $2.33M · Q3 2026
- Stonepine Capital Management, LLC 689.00K 股 · $1.61M · Q3 2026
- Atle Fund Management AB 663.77K 股 · $1.55M · Q3 2026
- Monashee Investment Management LLC 229.31K 股 · $534.29K · Q3 2026
更多关于 Decheng Capital LLC
常见问题
How long has Decheng Capital LLC held PYXS?
Decheng Capital LLC has disclosed PYXS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Decheng Capital LLC's current position in PYXS?
As of Q3 2026, Decheng Capital LLC holds 326.81K shares of PYXS (PYXIS ONCOLOGY INC), valued at $761.47K, representing 0.11% of its reported portfolio and ranking #11.
Has Decheng Capital LLC been buying or selling PYXS?
In the latest 13F filing (Q3 2026), Decheng Capital LLC held unchanged its position in PYXS. The position peaked in Q1 2024 at 326.81K shares.
Which other funds hold PYXS?
Other major institutional holders of PYXS include GordonMD Global Investments LP, PFIZER INC, Laurion Capital Management LP, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.